Consultation on infant formula and other products published
Australia
Jul 29, 2021
The purpose of this Application is to permit 2'-fucosyllactose (2'-FL), produced by microbial fermentation using genetically modified Escherichia coli (E.coli) strains, in infant formula products, follow-on formula and formulated supplementary foods for young children (FSFYC).
For further information (in English), click on the Link
Tags:
Nigeria/USA - Navigating regulatory challenges and safety considerations in lactation supplement development: A Nigeria and US Comparison
Nigeria
Apr 17, 2024
BFSA publishes draft Food Safety (Sample Collection, Testing, and Analysis) Regulations
Bangladesh
Apr 15, 2024
FDA Report on Economically Motivated Adulteration in Honey
USA
Apr 12, 2024
FDA warns about toxic yellow oleander in dietary supplements
USA
Apr 11, 2024
New max levels for T-2 and HT-2 toxins in food and grains
European Union
Apr 11, 2024
Bangladesh strengthens food recall systems
Bangladesh
Apr 11, 2024
Amendment to maximum levels of DON in food
European Union
Apr 10, 2024
EU - Food Safety and Hygiene: Current Policies, Quality Standards, and Scope of Artificial Intelligence.
European Union
Apr 10, 2024
Established EU reference laboratory for food improvement agents
European Union
Apr 10, 2024
FSA consults on the reform of authorization process for regulated products
UK
Apr 09, 2024
Amended maximum levels for the sum of 3-MCPD and 3-MCPD fatty acid esters in infant foods
European Union
Apr 08, 2024
Recommendations on the control of nickel in food
European Union
Mar 28, 2024
Draft Code of Practice for the prevention and reduction of lead contamination in food
Tanzania
Mar 27, 2024
CFIA assessment about Safe Food for Canadians Act review
Canada
Mar 27, 2024
FDA drat regulation on the use of extraction solvents in food production
Thailand
Mar 26, 2024